Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2006, p. 3479-3484, Vol. 50, No. 10
0066-4804/06/$08.00+0 doi:10.1128/AAC.00210-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
University of Alabama at Birmingham, Birmingham, Alabama,1 Wyeth Pharmaceuticals, Collegeville, Pennsylvania2
Received 17 February 2006/ Returned for modification 15 May 2006/ Accepted 23 July 2006
The activities of tigecycline and comparators against isolates collected from 76 U.S. centers between January 2004 and September 2005 were assessed. Tigecycline MIC90s were
2 µg/ml for Klebsiella pneumoniae, Klebsiella oxytoca, Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae, Serratia marcescens, Acinetobacter baumannii, Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, and Streptococcus agalactiae.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |